Syeda F Y Haque

Title: Syeda F Y Haque: Innovator in Human Antibodies

Introduction

Syeda F Y Haque is a prominent inventor based in London, GB. She has made significant contributions to the field of biotechnology, particularly in the development of human-derived antibodies. With a total of five patents to her name, her work has the potential to impact therapeutic and diagnostic applications.

Latest Patents

Among her latest patents is the development of human anti-IFN-α antibodies. This patent provides novel IFN-α binding molecules of human origin, specifically focusing on human-derived anti-IFN-α antibodies and their binding fragments, derivatives, and variants. Additionally, it describes pharmaceutical compositions, kits, and methods for use in diagnosis and therapy. Another notable patent involves CDNA encoding a monoclonal anti-IL-32 antibody, which includes novel IL-32 binding molecules of human origin. This patent also covers the production methods for the antibody, along with pharmaceutical compositions, kits, and diagnostic and therapeutic methods.

Career Highlights

Syeda F Y Haque is currently associated with Immunoqure AG, where she continues her innovative work in antibody development. Her expertise in the field has led to advancements that could significantly enhance treatment options for various diseases.

Collaborations

She has collaborated with notable professionals in her field, including Adrian Hayday and Kai Kisand. These collaborations have further enriched her research and development efforts.

Conclusion

Syeda F Y Haque is a trailblazer in the field of human antibodies, with a strong portfolio of patents that reflect her innovative spirit. Her contributions are poised to make a lasting impact on the medical and scientific communities.